ArticleJournal for immunotherapy of cancer2026

Membrane-bound TRAIL-armoring augments CAR-T cells in mesothelin-positive solid malignancies.

Alessia Volpe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.